Table 1 Patient baseline characteristics by indication for ICM implantations
From: Application of insertable cardiac monitors in the real world: an observational cohort study in China
Baseline characteristics | All patients (N = 200) | Indication for ICMs | ||
|---|---|---|---|---|
Syncope (N = 134) | Palpitation (N = 59) | Cryptogenic stroke (N = 7) | ||
Age(y): mean (sd) | 64.1(14.4) | 65.6(14.3) | 61.3(11.2) | 60.3 (5.2) |
Male, n(%) | 105(52.5) | 76 (56.7) | 26 (44.1) | 3 (42.9) |
Body Mass Index (kg/m2): mean (sd) | 25.2(4.1) | 25.3 (4.3) | 25.1(4.0) | 24.7(3.5) |
EF%: mean (sd) | 64.2(7.5) | 64.8(6.5) | 62.9 (9.5) | 65.5(5.8) |
EF% < 50%, n(%) | 10 (5.0) | 5 (3.7) | 5 (8.5) | 0 (0) |
Medical history, n(%) | ||||
Coronary artery disease | 81(40.5) | 57 (42.5) | 24 (40.7) | 0 (0) |
Myocardial infarction | 9 (4.5) | 5 (3.7) | 4 (6.8) | 0 (0) |
Hypertension | 130(65.0) | 92 (68.7) | 32 (54.2) | 6 (85.7) |
Diabetes mellitus | 61 (30.5) | 36 (26.9) | 20 (33.9) | 5 (71.4) |
Laboratory test | ||||
NT-proBNP, median (IQR), pg/mL | 191(64.1, 365.5) | 188(67.5, 296.0) | 259(56.7, 485.0) | 45.0 (31.7, 53.1) |
C-reactive protein (CRP), median (IQR), mg/dl | 1.1 (0.6, 4.3) | 1.1 (0.6, 4.4) | 1.3 (0.8, 3.3) | 0.7 (0.5, 17.0) |
Thyrotropin (TSH), median (IQR), mU/L | 0.4 (0.2, 0.6) | 0.4 (0.2, 0.6) | 0.3(0.2,0.4) | 0.3 (0.2, 0.40) |
HbA1c(%):mean (sd) | 6.1(1.1) | 6.3(1.2) | 6.3(1.0) | 5.84(0.85) |
Creatinine, median (IQR), µmoI/L | 74.2 (64.0, 90.3) | 75.2 (64.9, 93.1) | 72.9 (58.9, 83.3) | 69.4 (42.6, 71.5) |
LDL-C(mmol/L): mean (sd) | 2.5(0.7) | 2.5(0.7) | 2.7 (0.7) | 2.0(0.9) |
K+(mmol/L): mean (sd) | 4.0(0.4) | 4.1(0.4) | 4.0(0.4) | 3.8(0.3) |